Global pharma major Lupin Limited (Lupin) announced that it has received tentative approval from the United States Food and Drug Administration (FDA) under the US President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application for dolutegravir, emtricitabine and tenofovir alafenamide (DETAF) tablets. This product would be manufactured at Lupin
